Global Market for CRISPR Technology by End User, Application, Region and Key Company Profiles

News provided by

Jun 15, 2020, 15:00 ET

DUBLIN, June 15, 2020 /PRNewswire/ -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The scope of this report is broad, covering the applications of CRISPR in medicine, drug therapy and agriculture. The market for CRISPR technology is broken down by application and end user. Revenue forecasts from 2018-2023 are given for each end user category and application with estimated value derived from the revenue of the companies' total revenues.

This report also includes a discussion of the major players across each regional market for CRISPR technology with respect to prominent strategic initiatives. Furthermore, it explains the main drivers and regional dynamics of the global market and current trends within the industry.

The Report Includes:

45 data tables and 35 additional tables
An overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline in animal, human and other organisms
Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
Explanation of the major drivers and regional dynamics of the global CRISPR market and evaluation of its current market size, and market forecast
Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
Information on congenital anomalies, its prevalence, causes and its relation to mortality rate
Knowledge about Cell Line Engineering, CRISPR Plasmid, Genetic Engineering, GRNA Database/Gene Library and Human Stem Cells
Insights into regulatory framework and investment analysis
Market share analysis of the leading suppliers of the industry and their detailed company profiles, including Caribou Biosciences, Genscript, Integrated DNA Technologies, Intellia Therapeutics Inc., Precision Biosciences, Sangamo Therapeutics Inc., and Thermo Fisher Scientific

Key Topics Covered:

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

CRISPR: Genetic Editing
Pros of Genetic Editing
CRISPR Development Phases
Discovery of CRISPR
Discovery of Cas9 and PAM
Hypothesis: Adaptive Immunity
Adaptive Immunity
Spacer Sequences: gRNAs
CRISPR Acts on DNA Targets
Cas9 Cleaves Target DNA
tracrRNA for Cas9 Systems
CRISPR Systems in Other Species
Cas9-Mediated Cleavage
CRISPR-Cas9: Genome Editing
Market Potential
Regulatory Framework
U.S. Regulation and Oversight
NIH Guidelines
U.S. FDA
Ethical Considerations
Regulatory Issues
Regulations of Human Germline Edits
Global Regulations
Porter's Five Forces Analysis
Patent Analysis
Overview of CRISPR Technology Intellectual Property (IP) and Licensing Structure
Industry Drivers
CRISPR versus Disease
Government Funding
CRISPR in Other Fields
Industry Restraints
Alternative Technologies
Industry Challenges
Patent Issues

Chapter 4 Industry Structure

Commercial Therapeutics
Correcting Genetic Errors
Microbes
Healthier Food

Chapter 5 Competitive Landscape

Cellectis
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Sangamo Therapeutics

Chapter 6 Global Market for CRISPR Technology by End User

Academic Institutes
Research and Development Institutes
Pharmaceutical Companies
Biotechnology Companies

Chapter 7 Global Market for CRISPR Technology by Application

Cell Line Engineering
CRISPR Plasmid
Genetic Engineering
GRNA Databases/Gene Libraries
Human Stem Cells

Chapter 8 Global Market for CRISPR Technology by Region

North America
U.S.
Europe
UK
Asia-Pacific
China
India
Rest of the World

Chapter 9 Company Profiles

Caribou Biosciences
Crispr Therapeutics
Editas Medicine
Genscript
Horizon Discovery Plc
Integrated Dna Technologies
Intellia Therapeutics Inc.
Lonza Group Ltd.
New England Biolabs Inc.
Origene Technologies
Precision Biosciences
Sangamo Therapeutics Inc.
Thermo Fisher Scientific
Transposagenbio Biophramaceuticals (Hera Biolabs)

For more information about this report visit https://www.researchandmarkets.com/r/65nrk3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets